Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Miederer

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Clinical Nuclear Medicine|April 2, 2019
Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine TumorsAnna Yordanova, Harriet Ahrens, Georg Feldmann, et al.
Cancers|February 13, 2020
PSA and PSA Kinetics Thresholds for the Presence of <sup>68</sup>Ga-PSMA-11 PET/CT-Detectable Lesions in Patients With Biochemical Recurrent Prostate CancerManuela Andrea Hoffmann, Hans-Georg Buchholz, Helmut J Wieler, et al.
International Journal of Radiation Biology|December 9, 2021
mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposurePatrick Ostheim, Matthias Miederer, Mathias Schreckenberger, et al.
Cancers|April 12, 2022
Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial InsulinomatosisChristian Fottner, Stefanie Sollfrank, Mursal Ghiasi, et al.
Plos One|February 12, 2014
DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapyFranziska Graf, Jörg Fahrer, Stephan Maus, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Alpha-Emitting Radionuclides: Current Status and Future PerspectivesMatthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 2, 2025
Imaging-derived biomarkers from <sup>68</sup>Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with <sup>177</sup>Lu-DOTATATEStephan Raad, Ali Al-Fatlawi, C Louise Wise, et al.
Pharmaceuticals (Basel, Switzerland)|November 30, 2018
Evaluation of Radiolabeled Girentuximab In Vitro and In VivoTais Basaco, Stefanie Pektor, Josue M Bermudez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2013
High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PETMatthias Miederer, Christian Fottner, Heidi Rossmann, et al.
BJU International|August 23, 2025
Staging metastatic urothelial cancer with Nectin-4 imaging using Gallium-68-N188 PET/CTMatthias Miederer, Marc Pretze, Elena Abbate, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Clinical Nuclear Medicine|April 2, 2019
Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine TumorsAnna Yordanova, Harriet Ahrens, Georg Feldmann, et al.
Cancers|February 13, 2020
PSA and PSA Kinetics Thresholds for the Presence of <sup>68</sup>Ga-PSMA-11 PET/CT-Detectable Lesions in Patients With Biochemical Recurrent Prostate CancerManuela Andrea Hoffmann, Hans-Georg Buchholz, Helmut J Wieler, et al.
International Journal of Radiation Biology|December 9, 2021
mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposurePatrick Ostheim, Matthias Miederer, Mathias Schreckenberger, et al.
Cancers|April 12, 2022
Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial InsulinomatosisChristian Fottner, Stefanie Sollfrank, Mursal Ghiasi, et al.
Plos One|February 12, 2014
DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapyFranziska Graf, Jörg Fahrer, Stephan Maus, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Alpha-Emitting Radionuclides: Current Status and Future PerspectivesMatthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 2, 2025
Imaging-derived biomarkers from <sup>68</sup>Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with <sup>177</sup>Lu-DOTATATEStephan Raad, Ali Al-Fatlawi, C Louise Wise, et al.
Pharmaceuticals (Basel, Switzerland)|November 30, 2018
Evaluation of Radiolabeled Girentuximab In Vitro and In VivoTais Basaco, Stefanie Pektor, Josue M Bermudez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2013
High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PETMatthias Miederer, Christian Fottner, Heidi Rossmann, et al.
BJU International|August 23, 2025
Staging metastatic urothelial cancer with Nectin-4 imaging using Gallium-68-N188 PET/CTMatthias Miederer, Marc Pretze, Elena Abbate, et al.
Pageof 9